These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23840737)

  • 21. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
    Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
    Zhang C; Huang Z
    Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of Apoptosis in Human Leukemic Cell Lines by Diallyl Disulfide via Modulation of EGFR/ERK/PKM2 Signaling Pathways.
    Luo N; Zhao LC; Shi QQ; Feng ZQ; Chen DL; Li J
    Asian Pac J Cancer Prev; 2015; 16(8):3509-15. PubMed ID: 25921170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer.
    Sakamoto N; Oue N; Sentani K; Anami K; Uraoka N; Naito Y; Oo HZ; Hinoi T; Ohdan H; Yanagihara K; Aoyagi K; Sasaki H; Yasui W
    Cancer Sci; 2012 Sep; 103(9):1744-50. PubMed ID: 22676223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
    Zhang X; Liu T; Zheng S; Liu Q; Shen T; Han X; Zhang Q; Yang L; Lu X
    Oncol Rep; 2020 Oct; 44(4):1355-1364. PubMed ID: 32945483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling.
    Xue L; Su D; Li D; Gao W; Yuan R; Pang W
    Cell Biochem Biophys; 2015 May; 72(1):185-90. PubMed ID: 25542369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
    Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
    Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.
    Lee Y; Ko D; Yoon J; Lee Y; Kim S
    J Exp Clin Cancer Res; 2021 Mar; 40(1):58. PubMed ID: 33641663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
    Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.
    Li Q; Zhang D; Chen X; He L; Li T; Xu X; Li M
    Sci Rep; 2015 Nov; 5():16082. PubMed ID: 26542452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
    Li PY; Lv J; Qi WW; Zhao SF; Sun LB; Liu N; Sheng J; Qiu WS
    Oncol Rep; 2016 Jul; 36(1):448-54. PubMed ID: 27177197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ALDOLASE A regulates invasion of bladder cancer cells via E-cadherin-EGFR signaling.
    Li J; Wang F; Gao H; Huang S; Cai F; Sun J
    J Cell Biochem; 2019 Aug; 120(8):13694-13705. PubMed ID: 31081974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
    Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z
    Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
    Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
    Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.